Ale Algra
Professor emeritus Clinical epidemiology of the treatment and prevention of thrombosis
- Name
- Prof.dr. A. Algra
- a.algra@lumc.nl
- ORCID iD
- 0000-0003-2858-5808
My main field of research is vascular disease, in particular that of the brain.
Antithrombotic treatments
I was and am involved in several multicenter secondary prevention trials with antithrombotic treatments, mainly in patients with minor ischaemic stroke. One of these trials (SPIRIT) had to be stopped early because of a high frequency of major bleeding complications. This unanticipated finding forms a strong motive for my current research: why did these patients with minor ischaemic stroke of arterial origin have such a high bleeding propensity as compared with patients with other vascular diseases? And can we identify the patients prone to bleed and use that information to optimise antithrombotic treatment in the prevention of further ischaemic complications? I trust that my combined appointment at Leiden UMC and UMC Utrecht will be fruitful in addressing these questions.
The title of his inaugural lecture was 'Hoofdzaken'
Professor emeritus Clinical epidemiology of the treatment and prevention of thrombosis
- Faculteit Geneeskunde
- Divisie 2
- Reumatologie
- Klinische Epidemiologie
Contact
- Alons, IME; Goudsmit, BFJ; Jellema, K; van Walderveen, MAA; Wermer, MJH; Algra & A (2017), Yield of CT angiography in patients with acute headache, normal neurological examination and normal non-contrast CT: a meta-analysis., Journal of Stroke and Cerebrovascular Diseases.
- Adrichem, R.A. van; Nemeth, B.; Algra, A.; Cessie, S. le; Rosendaal, F.R.; Schipper, I.B.; Nelissen, R.G.H.H.; Cannegieter, S.C. & POT-KAST POT-CAST Grp (2017), Thromboprophylaxis after Knee Arthroscopy and Lower-Leg Casting, New England Journal of Medicine 376(6): 515-525.
- Alons, I.M.E.; Jellema, K.; Wermer, M.J.H. & Algra, A. (2016), D-dimer for the exclusion of cerebral venous thrombosis: a meta-analysis of low risk patients with isolated headache.
- CS Gathier WM van den Bergh JW Dankbaar RG Hoff WP Vandertop D Verbaan GJ Rinkel (2016), Spreading depolarization-modulating drugs and delayed cerebral ischemia after subarachnoid hemorrhage: A hypothesis-generating retrospective clinical study., Journal of the Neurological Sciences 366.
- Hamming, A.M.; Mulder, I.A.; Gathier, C.S.; Bergh, W.M. van den; Dankbaar, J.W.; Hoff, R.G.; Vandertop, W.P.; Verbaan, D.; Ferrari, M.D.; Rinkel, G.J.E.; Algra, A. & Wermer, M.J.H. (2016), Spreading depolarization-modulating drugs and delayed cerebral ischemia after subarachnoid hemorrhage: A hypothesis-generating retrospective clinical study, Journal of the Neurological Sciences 366: 224-228.
- Wijngaard, I.R. van den; Boiten, J.; Holswilder, G.; Algra, A.; Dippel, D.W.J.; Velthuis, B.K.; Wermer, M.J.H. & Walderveen, M.A.A. van (2015), Impact of Collateral Status Evaluated by Dynamic Computed Tomographic Angiography on Clinical Outcome in Patients With Ischemic Stroke, Stroke 46(12): 3398-3404.
- Maino, A.; Rosendaal, F.R.; Algra, A.; Peyvandi, F. & Siegerink, B. (2015), Hypercoagulability Is a Stronger Risk Factor for Ischaemic Stroke than for Myocardial Infarction: A Systematic Review, PLoS ONE 10(8).
- Wijngaard, I.R. van den; Algra, A.; Nijeholt, G.J.L.A.; Boiten, J.; Wermer, M.J.H. & Walderveen, M.A.A. van (2015), Value of Whole Brain Computed Tomography Perfusion for Predicting Outcome after TIA or Minor Ischemic Stroke, Journal of Stroke and Cerebrovascular Diseases 24(9): 2081-2087.
- Maino A., Siegerink B., Algra A., Peyvandi F. & Rosendaal F. R. (2015), Recurrence and mortality in young women with myocardial infarction or ischemic stroke: 19-year follow-up of the risk of arterial thrombosis in relation to oral contraceptives (RATIO) study, Journal of Thrombosis and Haemostasis 13: 192-192.
- Alons, I.M.E.; Wijngaard, I.R. van den; Verheul, R.J.; Nijeholt, G.L.A.; Wermer, M.J.H.; Algra, A. & Jellema, K. (2015), The value of CT angiography in patients with acute severe headache, Acta Neurologica Scandinavica 131(3): 164-168.
- Siegerink, B.; Maino, A.; Algra, A. & Rosendaal, F.R. (2015), Hypercoagulability and the risk of myocardial infarction and ischemic stroke in young women, Journal of Thrombosis and Haemostasis 13(9): 1568-1575.
- Van Dooren D., Rosendaal F., Algra A. & Siegerink B. (2015), Increased risk of ischaemic stroke with high levels of coagulation factor VIII activity in combination with oral contraceptives, International Journal of Stroke 10: 216-217.
- Roach, R.E.J.; Helmerhorst, F.M.; Lijfering, W.M.; Stijnen, T.; Algra, A. & Dekkers, O.M. (2015), Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke, Cochrane Database of Systematic Reviews.
- Zonneveld, T.P.; Algra, A.; Dippel, D.W.J.; Kappelle, L.J.; Oostenbrugge, R.J. van; Roos, Y.B.W.E.M.; Wermer, M.J.; Worp, H.B. van der; Nederkoorn, P.J.; Kruyt, N.D. & TRUTH Investigators (2015), The ThRombolysis in UnconTrolled Hypertension (TRUTH) protocol: an observational study on treatment strategy of elevated blood pressure in stroke patients eligible for IVT, BMC Neurology 15.
- Alons, I.M.E.; Jellema, K.; Wermer, M.J.H. & Algra, A. (2015), D-dimer for the exclusion of cerebral venous thrombosis: a meta-analysis of low risk patients with isolated headache.
- Siegerink, B.; Rosendaal, F.R. & Algra, A. (2014), Antigen levels of coagulation factor XII, coagulation factor XI and prekallikrein, and the risk of myocardial infarction and ischemic stroke in young women, Journal of Thrombosis and Haemostasis 12(5): 606-613.
- Beijnum, J. van; Wilkinson, T.; Bom, J.G. van der; Algra, A.; Berg, R. van den; Vandertop, W.P.; Brouwer, P.A.; Rinkel, G.J.E.; Kappelle, L.J.; Salman, R.A. & Klijn, C.J.M. (2013), THE RISK OF RUPTURE OF BRAIN ARTERIOVENOUS MALFORMATIONS DURING PREGNANCY, DELIVERY, AND THE PUERPERIUM: A CASE-CROSSOVER STUDY, Cerebrovascular Diseases 35: 131-131.
- Siegerink, B.; Maino, A.; Rosendaal, F.R. & Algra, A. (2013), Risk of myocardial infarction and ischaemic stroke and the impact of hypercoagulability - the RATIO case control study, Journal of Thrombosis and Haemostasis 11: 599-599.
- Siegerink, B.; Maino, A.; Rosendaal, F.R. & Algra, A. (2013), Risk of myocardial infarction and ischaemic stroke and the impact of hypercoagulability - the RATIO case control study, Cerebrovascular Diseases 35: 421-421.
- Siegerink, B.; Meltzer, M.E.; Groot, P.G. de; Algra, A.; Lisman, T. & Rosendaal, F.R. (2012), Clot lysis time and the risk of myocardial infarction and ischaemic stroke in young women; results from the RATIO case-control study, British Journal of Haematology 156(2): 252-258.
- Knol, M.J.; Cessie, S. le; Algra, A.; Vandenbroucke, J.P. & Groenwold, R.H.H. (2012), Overestimation of risk ratios by odds ratios in trials and cohort studies: alternatives to logistic regression, Canadian Medical Association Journal 184(8): 895-899.
- Vlak, M.H.M.; Rinkel, G.J.E.; Greebe, P.; Bom, J.G. van der & Algra, A. (2012), Trigger factors for rupture of intracranial aneurysms in relation to patient and aneurysm characteristics, Journal of Neurology 259(7): 1298-1302.
- Siegerink, B.; Rosendaal, F.R. & Algra, A. (2012), High-molecular-weight kininogen and the risk of a myocardial infarction and ischemic stroke in young women: the RATIO case-control study.
- Siegerink, B.; Rosendaal, F.R. & Algra, A. (2012), Family history differs between young women with myocardial infarction and ischemic stroke: Results from the RATIO case-control study, Atherosclerosis 223(1): 235-238.
- Andersson, H.M.; Siegerink, B.; Luken, B.M.; Crawley, J.T.B.; Algra, A.; Lane, D.A. & Rosendaal, F.R. (2012), High VWF, low ADAMTS13, and oral contraceptives increase the risk of ischemic stroke and myocardial infarction in young women, Blood 119(6): 1555-1560.
- Algra, A.M.; Klijn, C.J.M.; Helmerhorst, F.M.; Algra, A. & Rinkel, G.J.E. (2012), Female risk factors for subarachnoid hemorrhage A systematic review, Neurology 79(12): 1230-1236.
- Vlak, M.H.M.; Rinkel, G.J.E.; Greebe, P.; Bom, J.G. van der & Algra, A. (2011), Trigger Factors and Their Attributable Risk for Rupture of Intracranial Aneurysms A Case-Crossover Study, Stroke 42(7): 1878-1882.
- Man, S.; Algra, A.M.; Schreurs, C.A.; Borleffs, C.J.W.; Scherptong, R.W.C.; Erven, L. van; Wall, E.E. van der; Cannegieter, S.C.; Schalij, M.J. & Swenne, C.A. (2011), Influence of the vectorcardiogram synthesis matrix on the power of the electrocardiogram-derived spatial QRS-T angle to predict arrhythmias in patients with ischemic heart disease and systolic left ventricular dysfunction, Journal of Electrocardiology 44(4): 410-415.
- Siegerink, B.; Andersson, H.M.; Luken, B.M.; Crawley, J.T.B.; Algra, A.; Lane, D.A. & Rosendaal, F.R. (2011), VWF and ADAMTS13 levels and the risk of myocardial infarction and ischaemic stroke in young women: results from the ratio case-control study.
- Winckers, K.; Siegerink, B.; Duckers, C.; Maurissen, L.F.; Tans, G.; Castoldi, E.; Spronk, H.M.H.; Cate, H. ten; Algra, A.; Hackeng, T.M. & Rosendaal, F.R. (2011), Increased tissue factor pathway inhibitor activity is associated with myocardial infarction in young women: results from the RATIO study.
- Pruissen, D.M.O.; Rosendaal, F.R.; Frijns, C.J.M.; Kappelle, L.J.; Vos, H.L.; Algra, A. & SMART Study Grp (2011), Prothrombotic Gene Variants and Mortality after Cerebral Ischemia of Arterial Origin, Neuroepidemiology 37(2): 109-113.
- Brouwer, B.G.; Visseren, F.L.J.; Algra, A.; Bockel, J.H. van; Bollen, E.L.E.M.; Doevendans, P.A.; Greving, J.P.; Kappelle, L.J.; Moll, F.L.; Pijl, H.; Romijn, J.A.; Wall, E.E. van der & Graaf, Y. van der (2010), Effectiveness of a hospital-based vascular screening programme (SMART) for risk factor management in patients with established vascular disease or type 2 diabetes: a parallel-group comparative study, Journal of Internal Medicine 268(1): 83-93.
- Dekkers, O.M.; Elm, E. von; Algra, A.; Romijn, J.A. & Vandenbroucke, J.P. (2010), How to assess the external validity of therapeutic trials: a conceptual approach, International Journal of Epidemiology 39(1): 89-94.
- Siegerink, B.; Govers-Riemslag, J.W.P.; Rosendaal, F.R.; Cate, H. ten & Algra, A. (2010), Intrinsic Coagulation Activation and the Risk of Arterial Thrombosis in Young Women Results From the Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) Case-Control Study, Circulation 122(18): 1854-1861.
- Man, S.; Algra, A.M.; Schreurs, C.A.; Cannegieter, S.C.; Wall, E.E. van der; Schalij, M.J.; Kors, J.A. & Swenne, C.A. (2010), Accuracy of spatial QRS-T angles: differences between measurements done in standard 12-lead ECGs and in Frank VCGs, European Heart Journal 31: 286-286.
- Groenestege ATT, Rinkel GJE, van der Bom JG, Algra A & Klijn CJM (2009), The Risk of Aneurysmal Subarachnoid Hemorrhage During Pregnancy, Delivery, and the Puerperium in the Utrecht Population Case-Crossover Study and Standardized Incidence Ratio Estimation, Stroke 40(4): 1148-1151.
- Pruissen DMO, Kappelle LJ, Rosendaal FR & Algra A (2009), Prothrombotic genetic variants and atherosclerosis in patients with cerebral ischemia of arterial origin, Atherosclerosis 204(1): 191-195.
- Siegerink, B.; Algra, A. & Rosendaal, F.R. (2009), Genetic variants of coagulation factor XIII and the risk of myocardial infarction in young women, British Journal of Haematology 146(4): 459-461.
- Wermer MJH, Greebe P, Algra A & Rinkel GJE (2009), Long-term mortality and vascular event risk after aneurysmal subarachnoid haemorrhage, Journal of Neurology, Neurosurgery and Psychiatry 80(12): 1399-1401.
- Urbanus, R.T.; Siegerink, B.; Roest, M.; Rosendaal, F.R.; Groot, P.G. de & Algra, A. (2009), Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study, The Lancet Neurology 8(11): 998-1005.
- Siegerink, B.; Rosendaal, F.R. & Algra, A. (2009), Genetic variation in fibrinogen; its relationship to fibrinogen levels and the risk of myocardial infarction and ischemic stroke, Journal of Thrombosis and Haemostasis 7(3): 385-390.
- Siegerink B, Rosendaal FR & Algra A (2009), Genetic variation in fibrinogen; its relationship to fibrinogen levels and the risk of myocardial infarction and ischemic stroke., Journal of Thrombosis and Haemostasis 7(3): 385-90.
- Pruissen DMO, Rosendaal FR, Frijns CJM, Kappelle LJ, Vos HL & Algra A (2008), Prothrombotic gene variation and new vascular events after cerebral ischemia of arterial origin, Journal of Thrombosis and Haemostasis 6(10).
- Pruissen DMO, Kappelle LJ, Rosendaal FR & Algra A (2008), Prothrombotic gene variation in patients with large and small vessel disease, Neuroepidemiology 31(2).
- Martijn D, Pruissen O, Slooter AJC, Rosendaal FR, van der Graaf Y & Algra A (2008), Coagulation factor XIII gene variation, oral contraceptives, and risk of ischemic stroke, Blood 111(3).
- Pruissen DMO, Rosendaal FR, Gorter JW, Garcia AA, Kappelle LJ & Algra A (2007), Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin, Journal of Neurology 254(12).
- Manschot SM, Biessels GJ, de Valk H, Algra A, Rutten GEHM, van der Grond J & Kappelle LJ (2007), Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes, Diabetologia 50(11).
- Tanis B, Algra A, van der Graaf Y, Helmerhorst F & Rosendaal F (2006), Procoagulant factors and the risk of myocardial infarction in young women, European Journal of Haematology 77(1).
- Manschot SM, Brands AMA, van der Grond J, Kessels RPC, Algra A, Kappelle LJ & Biessels GJ (2006), Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes, Diabetes 55(4).
- Slooter AJC, Rosendaal FR, Tanis BC, Kemmeren JM, Van der Graaf Y & Algra A (2005), Prothrombotic conditions, oral contraceptives, and the risk of ischemic stroke, Journal of Thrombosis and Haemostasis 3(6).
- Gorter PM, Olijhoek JK, van der Graaf Y, Algra A, Rabelink TJ & Visseren FLJ (2004), Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm, Atherosclerosis 173(2).
- Olijhoek JK, van der Graaf Y, Banga JD, Algra A, Rabelink TJ & Visseren FLJ (2004), The Metabolic Syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm, European Heart Journal 25(4).
- Tanis BC, Blom HJ, Bloemenkamp DGM, Van den Bosch MAAJ, Algra A, Van der Graaf Y & Rosendaal FR (2004), Folate, homocysteine levels, methylenetetrahydrofolate reductase (MTHFR) 677C -> T variant, and the risk of myocardial infarction in young women: effect of female hormones on homocysteine levels, Journal of Thrombosis and Haemostasis 2(1).
- Van Den Bosch MAAJ, Kemmeren JM, Tanis BC, Mali WPTM, Helmerhorst FM, Rosendaal FR, Algra A & Van Der Graaf Y (2003), The RATIO study: oral contraceptives and the risk of peripheral arterial disease in young women, Journal of Thrombosis and Haemostasis 1(3).
- van den Bosch MAAJ, Bloemenkamp DGM, Mali WPTM, Kernmeren JM, Tanis BC, Algra A, Rosendaal FR & van der Graaf Y (2003), Hyperhomocysteinemia and risk for peripheral arterial occlusive disease in young women, Journal of Vascular Surgery 38(4).
- Tanis BC, Bloemenkamp DGM, van den Bosch MAAJ, Kemmeren JM, Algra A, van de Graaf Y & Rosendaal FR (2003), Prothrombotic coagulation defects and cardiovascular risk factors in young women with acute myocardial infarction, British Journal of Haematology 122(3).
- Bloemenkamp DGM, Mali WPTM, Tanis BC, Rosendaal FR, van den Bosch MAAJ, Kemmeren JM, Algra A, Ossewaarde JM, Visseren FLJ, van Loon AM & van der Graaf Y (2002), Chlamydia pneumoniae, Helicobacter pylori and cytomegalovirus infections and the risk of peripheral arterial disease in young women, Atherosclerosis 163(1).
- Kemmeren JM, Tanis BC, van den Bosch MAAJ, Bollen ELEM, Helmerhorst FM, van der Graaf Y, Rosendaal FR & Algra A (2002), Risk of arterial thrombosis in relation to oral contraceptives (RATIO) study - Oral contraceptives and the risk of ischemic stroke, Stroke 33(5).
- Bloemenkamp DGM, Mali WPTM, Tanis BC, Rosendaal FR, van den Bosch MAAJ, Kemmeren JM, Algra A, Visseren FLJ & van der Graaf Y (2002), The relation between Helicobacter pylori and atherosclerosis cannot be explained by a high homocysteine concentration, European Journal of Clinical Investigation 32(8).
- van den Bosch MAAJ, Mali WPTM, Bloemenkamp DGM, Eikelboom BC, Kemmeren JM, Tanis BC, Algra A, Rosendaal FR & van der Graaf Y (2002), Increased pregnancy loss in young women with aortoiliac disease, Atherosclerosis 164(1).
- Bloemenkamp DGM, van den Bosch MAAJ, Mali WPTM, Tanis BC, Rosendaal FR, Kernmeren JM, Algra A, Visseren FLJ & van der Graaf Y (2002), Novel risk factors for peripheral arterial disease in young women, American Journal of Medicine 113(6).
- Torn M, Algra A & Rosendaal FR (2001), Oral anticoagulation for cerebral ischemia of arterial origin - High initial bleeding risk, Neurology 57(11).
- Tanis BC, van den Bosch MAAJ, Kemmeren JM, Cats VM, Helmerhorst FM, Algra A, van der Graaf Y & Rosendaal FR (2001), Oral contraceptives and the risk of myocardial infarction., New England Journal of Medicine 345(25).